open access

  • Abstract viewed - 298 times
  • PDF downloaded - 284 times
Submitted: 2022-01-14
DOI: 10.35119/myjo.v4i2.260
Case Reports
Published: 2022-07-08

Treatment of primary vasoproliferative tumor of the retina using laser photocoagulation and intravitreal ranibizumab

Department of Ophthalmology, Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia; Department of Ophthalmology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
Department of Ophthalmology, Hospital Tengku Ampuan Afzan Kuantan, Pahang, Malaysia
Department of Ophthalmology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; University Malaya Eye Research Centre, University Malaya Medical Centre, Kuala Lumpur, Malaysia
epiretinal membrane intravitreal ranibizumab laser photocoagulation vasoproliferative tumour of the retina

Abstract

Background: Vasoproliferative tumours (VPT) of the retina are benign, uncommon tumours that occur mostly in patients with no other ocular pathology. Several treatment modalities are used to treat these tumours including cryotherapy, laser photocoagulation, anti-VEGF injection, and observation.
Case presentation: We present a case of a 40-year-old female with retinal VPT. The patient received a combination of selective laser photocoagulation of the tumour and serial intravitreal injections of ranibizumab that resulted in regression of the VPT and good visual outcome.
Conclusion: Laser photocoagulation treatment should be considered for treating primary retinal VPT as it is the most available treatment modality. Combination therapy laser photocoagulation treatment with anti-VEGF provides long-term tumour regression, which is effective for the macular oedema associated with this condition.